ALLISON FAYANS: Open Payments
NPI 1336649193 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 22 payments from 9 companies in 2025. Trend: 2023 $348 · 2024 $553 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $297 |
| AstraZeneca Pharmaceuticals LP | 2 | $186 |
| Kestra Medical Technology Services, Inc. | 11 | $160 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $144 |
| Novartis Pharmaceuticals Corporation | 1 | $135 |
| Novo Nordisk Inc | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $110 |
| ABIOMED | 1 | $42 |
| HEARTFLOW, INC. | 1 | $16 |
Products named: AMVUTTRA, WAINUA, Assure WCD, LifeVest, LEQVIO, Ozempic, FFRct.
Industry payments across NJ — which companies pay providers there.
